cas 887581-47-7|| where to buy 6-chloro-3-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

製品名:6-chloro-3-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

IUPAC Name:6-chloro-3-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

包装単位	有効在庫	価格（USD）
CM467305-100mg	in stock	ȎȀȀ
CM467305-250mg	in stock	ŢǯǊ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 887581-47-7 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:887581-47-7; 分子式:C7H9ClN2O2; 融点:-; SMILESコード:CC(C)N1C(=O)NC(Cl)=CC1=O; 密度:

: カタログ番号:CM467305; 分子量:188.61; 沸点:; MDL番号:MFCD03001443; 保管方法:

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: Mavacamten; CAMZYOS(Mavacamten) was recently approved in the European Union, following its approval in the U.S. and other markets worldwide, and is the first and only cardiac myosin inhibitor approved to treat adult patients with symptomatic obstructive hypertrophic cardiomyopathy(HCM).
Mavacamten is a first-in-class, targeted inhibitor of cardiac myosin, reduces the number of myosin-actin cross-bridges and thus decreases excessive contractility characteristic of HCM.